STEMMEE

Stemmee is a South Korean biotechnology company focused on developing next-generation regenerative therapies using stem-cell-derived extracellular vesicles (EVs). The company's core technology involves the mass production and purification of high-quality exosomes that harness the regenerative potential of stem cells without the risks associated with live cell transplantation. Stemmee's lead programs target dermatological and inflammatory conditions, including atopic dermatitis and hair loss. By utilizing the paracrine signaling mechanisms of EVs, the company aims to provide safer and more stable alternatives to traditional cell-based treatments. The firm is a spin-off from Pusan National University and leverages advanced cell culture techniques to ensure therapeutic efficacy.